2025 And 2025 Calendar Targeted Therapy. Thank you to those who joined us for #ttlc24! P53, encoded by tp53, the commonest mutated gene in cancer, is an appealing target for systemic anticancer therapies including those designed to restore.
Tolerance & resistance to targeted therapy in nsclc. Targeted alpha therapy using radium223 from physics to biological, clinical approval of 223 racl 2 in 2013 was a major milestone in the widespread application of tat as a safe.